TREATMENT OF RHEGMATOGENOUS RETINAL DETACHMENT, COMPLICATED BY PROLIFERATIVE VITREORETINOPATHY (REVIEW)

Author: Fabrikantov O.L.¹, Konyaev D.A.², Osmanov R.E.³

Abstract

We have summarized the results of national and foreign studies dealing with the questions of proliferative vitreoretinopathy (PVR) pathogenesis, treatment and prophylaxis. Rhegmatogenous retinal detachment (RRD) is one of the most severe ocular diseases that very often leads to the significant reduction of visual functions, disability and if untreated to irreversible blindness. Many studies have proved that the postoperative functional result depends on a number of factors including the severity of proliferative retinopathy. PVR is a term that is inseparably linked with the description of a wide spectrum of vitreoretinal pathology accompanied by the processes of pathological membrane formation on the retinal surface and in the vitreous body, leading eventually to the irreversible and inoperable changes. Currently surgical method of PVR treatment is considered the most effective. Surgical technique in PVR depends on the stage of the disease. PVR diagnosis in the early stages is problematic, and the disease is diagnosed when discovering the epi- and/or subretinal proliferative membranes been already formed. Currently there are no criteria for assessing the possibility of PVR development and progression followed surgical treatment. Despite modern advances in the study of PVR etiology and pathogenesis, the improvement of surgical techniques of treating RRD, the problem of proliferative disease prevention and treatment remains topical and requires further treatment.

Key words

ophthalmology, proliferative vitreoretinopathy, rhegmatogenous retinal detachment

References

Chang Y.-C, Hu D.-N., Wu W.-C. Effect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathy // Am. J. Ophthalmol. 2008. 146. (3). 440-446.

Charles S., Calzada J., Wood B. Vitreous microsurgery. Moscow: MEDpress-inform, 2012. 226-243. [In Russian].

Charteris D.G., Aylward G.W., Wong D., Groenewald C., Asaria R.H., Bunce C. A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy // Ophthalmology. 2004. 111. (12). 2240-2245.

Cui J.Z., Chiu A., Maberley D., Ma P., Samad A., Matsubara J.A. Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy // Eye (Lond.). 2007. 21. (2). 200-208.

Egorov A.V. Current opportunities to improve functional activity of the retina followed retinal detachment surgery // Sovremennyye tekhnologii v oftal'mologii = Modern technologies in ophthalmology. 2015 (2). 78. [In Russian].

Fabrikantov O.L., Shmykov A.V. The role of vitreoretinal interface in retinal detachment pathogenesis // Vestnik Orenburgskogo gosudarstvennogo universiteta = Vestnik of the Orenburg State University. 2013. (4). 280-282. [In Russian].

Gil'manshin T.R., Fayzrakhmanov G.R., Yarmukhametova A.I., Zaynullina S.R. The impact of “Kenalog” on proliferative vitreoretinopathy development followed surgical treatment of rhegmatogenous retinal detachment // “East-West": coll. proc. sci. pract. conf. on ophthalmic surgery with international participation, Ufa, June 7–8, 2012. Ufa, 2012. 272-273. [In Russian].

Glinchuk Ya.I., Sidorenko V.G., Kashtan O.V., Shkvorchenko D.O. Surgical treatment outcomes of detachment and retinal detachment relapses, complicated by severe proliferative retinopathy // Oftal'mokhirurgiya = Fyodorov Journal of Ophthalmic Surgery. 1994. (2). 20-25. [In Russian].

Kanski D.D., Milevski S.A., Damato B.E., Tanner V. Diseases of the ocular fundus. Moscow: MEDpress-inform, 2009. 268-270. [In Russian].

Kashtan O.V., Timokhov V.L., Konovalov K.A. Bilateral traction retinal detachment in association with secondary proliferative vitreoretinopathy caused by intravenous administration of coaxil (a clinical case) // "Modern technologies of vitreoretinal pathology treatment": coll. thes. VII sci. pract. conf., Moscow, March 19–20, 2009. Moscow, 2009. 104-105. [In Russian].

Kreissig I. Minimal surgery for retinal detachment: a practical guide. N.Y., 2000. 356 p.

Mashchenko N.V., Khudyakov A.Yu., Lebedev Ya.B. Comparative analysis of surgical treatment of primary rhegmatogenous retinal detachment by episcleral and vitreal surgery // Sovremennye tekhnologii v oftal'mologii = Modern technologies in ophthalmology. 2014. (1). 77. [In Russian].

Osmanov R.E. Clinical epidemiological aspects of rhegmatogenous retinal detachment in Tambov region // Sovremennye tekhnologii v oftal'mologii = Modern technologies in ophthalmology. 2016. (4). 168-170. [In Russian].

Osmanov R.E. Current methods of rhegmatogenous retinal detachment surgical treatment // Vestnik Tambovskogo Universiteta. Seriya: Yestestvennyye i tekhnicheskiye nauki = Tambov University Reports. Series: Natural and Technical sciences. 2015. 20. (3). 658-662. [In Russian].

Osmanov R.E. Medical epidemiological analysis of prevalence and surgical treatment of rhegmatogenous retinal detachment in Tambov region within 2006-2015 // Tochka zreniya. Vostok - Zapad = Point of view. East – West. 2016. (2). 17-21. [In Russian].

Osmanov R.E. Prevalence of rhegmatogenous retinal detachment in Tambov region // Vestnik Tambovskogo Universiteta. Seriya: Yestestvennyye i tekhnicheskiye nauki = Tambov University Reports. Series: Natural and Technical sciences. 2015. 20 (6). 1666-1669. [In Russian].

Osmanov R.E., Fabrikantov O.L., Osmanov E.M. To the question about treatment of rhegmatogenous retinal detachment // Vestnik Tambovskogo Universiteta. Seriya: Yestestvennyye i tekhnicheskiye nauki = Tambov University Reports. Series: Natural and Technical sciences. 2014. 19. (6). 1948-1950. [In Russian].

Pastor-Idoate S., Rodriguez-Hernandez I., Rojas J., Fernandez I., Garcia-Gutierrez M.T., Ruiz-Moreno J.M., Rocha-Sousa A., Ramkissoon Y., Harsum S., Maclaren R.E., Charteris D., van Meurs J., Gonzalez-Sarmiento R., Pastor J.C.. The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: The Retina 4 Project // Ophthalmology. 2013. 120. (3). 623-628.

Putienko A.A., Aslanova V.S. Retinal detachment. Odessa, 2014. 7-11. [In Russian].

Rojas J., Fernandez I., Pastor J.C., Garcia-Gutierrez M.T., Sanabria R.M., Brion M., Sobrino B., Manzanas L., Giraldo A., Rodriguez-de la Rua E., Carracedo A. Development of predictive models of proliferative vitreoretinopathy based on genetic variables: the Retina 4 Project // Invest. Ophthalmol. Vis. Sci. 2009. 50. (5). 2384-2390.

Sanabria Ruiz-Colmenares M.R., Pastor Jimeno J.C., Garrote Adrados J.A., Telleria Orriols J.J., Yugueros Fernandez M.I. Cytokine gene polymorphisms in retinal detachment patients with and without proliferative vitreoretinopathy: a preliminary study // Acta Ophthalmol. Scand. 2006. 84. (3). 309-313.

Shmykov A.V., Fabrikantov O.L., Avdeev R.V., Vedrinceva N.V. Induction of posterior vitreous detachment in episcleral sealing on the eyes with rhegmatogenous detachment // Vestnik Orenburgskogo gosudarstvennogo universiteta = Vestnik of the Orenburg State University. 2013. (4). 307-310. [In Russian].

Shmykov A.V., Fabrikantov O.L., Avdeev R.V., Vedrinceva N.V. The outcomes of using gemasa in surgical treatment of rhegmatogenous retinal detachments with local parietal hemophthalmus // Vestnik Tambovskogo Universiteta. Seriya: Yestestvennyye i tekhnicheskiye nauki = Tambov University Reports. Series: Natural and Technical sciences. 2015. 20. (3). 719-722. [In Russian].

Sosnovskiy S.V., Boyko E.V., Kharitonova N.N. Basis and working out the quantitative assessment of proliferative vitreoretinopathy severity // Oftal'mokhirurgiya = Fyodorov Journal of Ophthalmic Surgery. 2009. (4). 25-29. [In Russian].

Stebnev V.S. Malov V.M. Recurrences of retinal detachment related with progression of proliferative vitreoretinopathy after the primary endovitreal surgery of rhegmatogenous retinal detachment // Vestnik Orenburgskogo gosudarstvennogo universiteta = Vestnik of the Orenburg State University. 2009. (12). 131-134. [In Russian].

Takhchidi Kh.P., Zakharov V.D. Retina and vitreous surgery. Moscow: Ophthalmology, 2011. 186 p.

Tikhonovich M.V., Ioyleva E.E. The role of vascular endothelial growth dactor in retinal physiology // Vestnik Orenburgskogo gosudarstvennogo universiteta = Vestnik of the Orenburg State University. 2015. (12). 244-249. [In Russian].

Tikhonovich M.V., Ioyleva E.E., Gavrilova S.A. The role of inflammation in the development of proliferative vitreoretinopathy // Klinicheskaya meditsina = Clinical medicine. 2015. 93. (7). 14-20. [In Russian].

Tikhonovich M.V., Lyskin P.V., Ioyleva E.E., Davydova M.P., Gavrilova S.A. Expression of growth, trophic and inflammation factors in epiretinal membranes in patients with severe proliferative vitreoretinopathy // Oftal'mokhirurgiya = Fyodorov Journal of Ophthalmic Surgery. 2015. (4). 36. [In Russian].

Velichko P.B., Fabrikantov O.L., Osmanov R.E. Social and hygienic characteristics of proliferative diabetic retinopathy patients // Vestnik Tambovskogo Universiteta. Seriya: Yestestvennyye i tekhnicheskiye nauki = Tambov University Reports. Series: Natural and Technical Sciences. 2014. 19. (2). 741-743. [In Russian].

Wickham L., Bunce C., Wong D., McGurn D., Charteris D.G. Randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy // Ophthalmology. 2007. 114. (4). 698-704.

Wiedemann P., Hilgers R.D., Bauer P., Heimann K. Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group // Am. J. Ophthalmol. 1998. 126. (4). 550-559.

Zakharov V.D. Vitreoretinal surgery. Moscow, 2003. 180 p.

Zakharov V.D., Khusseyn M.I. Peculiarities of vitreoretinal surgery in retinal detachments, complicated by anterior proliferative vitreoretinopathy // Oftal'mokhirurgiya = Fyodorov Journal of Ophthalmic Surgery. 2007 (1). 38–41. [In Russian].

About Authors (Correspondence):

Fabrikantov O.L. – doctor of medical sciences, director, head of ophthalmological department, email: naukatmb@mail.ru

Full Text

snmzh_1-2018_fabrikantov_i_dr.pdf

Received: 26/02/2018

Accepted: 26/02/2018